The problem with that is saying no delays is just a surface answer. It needs to be delved into by investors to get more information so they can be aware of everything going on, especially with the track record we have seen over the last year.
It's up to investors to ask questions and get answers and these calls are important. The NGIO call was an important call because then, direct questions could have been posed, then follow-up (hopefully) questions could have drilled down to more specifics.
(0)
(0)
Generex Biotechnology Corp. (GNBTQ) Stock Research Links